Capital Advisory Group Advisory Services, LLC Sarepta Therapeutics, Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

$210 Million
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $3,298 - $4,624	-50 Closed	0 $0
Q2 2021 Nov 12, 2021	BUY	$69.38 - $86.75 $3,469 - $4,337	50 New	50 $4,000

Others Institutions Holding SRPT

# of Institutions

471

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

Vanguard Group Inc Valley Forge, PA

8.8M
Shares

$1.33 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.96M
Shares

$903 Million
0.02% of portfolio
Janus Henderson Group PLC London, X0

4.89M
Shares

$741 Million
0.36% of portfolio
Capital International Investors Los Angeles, CA

4.82M
Shares

$730 Million
0.13% of portfolio
Avoro Capital Advisors LLC New York, NY

4.34M
Shares

$658 Million
6.78% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account